Hepatic resection for metastatic neuroendocrine carcinomas

https://doi.org/10.1016/S0002-9610(99)80107-XGet rights and content

Background

Metastatic neuroendocrine malignancies frequently cause incapacitating endocrinopathies, and metastases predominant in the liver. Hepatic resection of metastases from such tumors is attractive because the natural history of neuroendocrine tumors is protracted, clinical severity of the endocrinopathy correlates with tumor volume, and local and intrahepatic growth characteristics often allow complete resection.

Patients and methods

To define the role of hepatic resection for metastatic neuroendocrine tumors, the records of 74 patients who underwent hepatic resection for such tumors between 1984 and 1992 were reviewed. Neuroendocrine tumors were classified by site of origin and clinical endocrinopathy. Survival, and type and duration of symptomatic response, were assessed as the major outcomes of this study.

Results

There were 50 carcinoid, 23 islet-cell, and 1 atypical neuroendocrine tumors. Resections included 36 hemihepatectoinies or extended hepatectomies and 38 nonanatomic resections. Thirty-eight primary tumors were resected concomitantly. Perioperative mortality was 2.7% and morbidity was 24%. Four-year survival was 73%. Overall postoperative symptomatic response rate was 90% with a mean duration of response of 19.3 months.

Conclusions

Hepatic resection for metastatic neuroendocrine malignancies is safe, provides effective palliation, and probably prolongs survival.

References (31)

  • LobeTE et al.

    Hepaticopancreaticogastroduodenectomy with transplantation for metastatic islet cell carcinoma in childhood

    J Pediatr Surg.

    (1992)
  • StephenJL et al.

    Treatment of the carcinoid syndrome by local removal of hepatic metastases

  • StrodelWE et al.

    Surgical therapy for small-bowel carcinoid tumors

    Arch Surg.

    (1983)
  • NortonJA et al.

    Aggressive resection of metastatic disease in selected patients with malignant gastrinoma

    Ann Surg.

    (1986)
  • McEnteeGP et al.

    Cytoreductive hepatic surgery for neuroendocrine tumors

    Surgery.

    (1990)
  • MakridisC et al.

    Surgical treatment of midgut carcinoid tumors

    World J Surg.

    (1990)
  • SoreideO et al.

    Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors

    Surgery.

    (1992)
  • GramaD et al.

    Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes

    World J Surg.

    (1992)
  • AhlmanH et al.

    Management of disseminated midgut carcinoid tumours

    Digestion.

    (1991)
  • GotoH et al.

    A glucagon-secreting alphacell carcinoma of the pancreas

    World J Surg.

    (1982)
  • NagorneyDM et al.

    Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma

    Surgery.

    (1983)
  • TravisWD et al.

    Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma

    Am J Surg Pathol.

    (1991)
  • KaplanEL et al.

    Nonparametric estimation from incomplete observations

    J Am Stat Assoc.

    (1958)
  • PetoR et al.

    Asymptotically efficient rank invariant test procedures

    J Roy Stat Soc.

    (1972)
  • FosterJH

    Survival after liver resection for cancer

    Cancer.

    (1970)
  • Cited by (419)

    • ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update

      2022, Journal of the American College of Radiology
    • Treatment strategies for neuroendocrine liver metastases: a systematic review

      2022, HPB
      Citation Excerpt :

      Although these results involve a lower chance of surgical resection, these two types may undergo locoregional treatment followed by resection, or staged hepatectomy.38 In fact, many reports have shown the advantages regarding survival and symptom control by surgical resection, superior to other treatments, as reported by the reviewed studies.8–19 Additionally, some authors reported the feasibility of performing the combined resection of the primary tumor with metastases to obtain the complete resection R0.

    View all citing articles on Scopus
    View full text